REATA PHARMACEUTICALS INC Interest Expense
REATA PHARMACEUTICALS INC reported Interest Expense of $1.31 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2023-08-08
- REATA PHARMACEUTICALS INC interest expense for the quarter ending 2023-06-30 was $1.31M.
- REATA PHARMACEUTICALS INC interest expense for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- REATA PHARMACEUTICALS INC interest expense for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- REATA PHARMACEUTICALS INC interest expense for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- REATA PHARMACEUTICALS INC interest expense for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- REATA PHARMACEUTICALS INC interest expense for fiscal 2021 was $6.56M, a 55.94% decline from fiscal 2020.
- REATA PHARMACEUTICALS INC interest expense for fiscal 2020 was $14.89M, a 33.03% increase from fiscal 2019.
- REATA PHARMACEUTICALS INC interest expense for fiscal 2019 was $11.20M, a 81.30% increase from fiscal 2018.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2023-06-30 | $1.31M 10-Q · filed 2023-08-08 | $1.31M 10-Q · filed 2023-08-08 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $0.00 derived: sum of 3 quarters · filed 2023-02-24 | $0.00 10-K · filed 2023-02-24 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $0.00 10-Q · filed 2022-11-08 | $1.24M derived: sum of 4 quarters · filed 2023-02-24 |
| 2022-06-30 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $1.24M derived: sum of 3 quarters · filed 2023-02-24 | $3.08M derived: sum of 4 quarters · filed 2023-02-24 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | $1.24M derived: sum of 2 quarters · filed 2023-02-24 | $3.08M derived: sum of 3 quarters · filed 2023-02-24 | $4.85M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $3.08M derived: sum of 2 quarters · filed 2023-02-24 | $4.85M derived: sum of 3 quarters · filed 2023-02-24 | $6.56M 10-K · filed 2023-02-24 |
| 2021-09-30 | $1.83M 10-Q · filed 2022-11-08 | $3.61M derived: sum of 2 quarters · filed 2022-11-08 | $5.32M 10-Q · filed 2022-11-08 | $7.03M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $1.77M 10-Q · filed 2022-08-08 | $3.49M 10-Q · filed 2022-08-08 | $5.20M derived: sum of 3 quarters · filed 2023-02-24 | $6.87M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $1.71M 10-Q · filed 2022-05-10 | $3.43M derived: sum of 2 quarters · filed 2023-02-24 | $5.10M derived: sum of 3 quarters · filed 2023-02-24 | $10.74M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $3.38M derived: sum of 2 quarters · filed 2023-02-24 | $9.03M derived: sum of 3 quarters · filed 2023-02-24 | $14.89M 10-K · filed 2023-02-24 |
| 2020-09-30 | $1.67M 10-Q · filed 2021-11-08 | $7.32M derived: sum of 2 quarters · filed 2021-11-08 | $13.18M 10-Q · filed 2021-11-08 | $17.18M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $5.64M 10-Q · filed 2021-08-09 | $11.51M 10-Q · filed 2021-08-09 | $15.51M derived: sum of 3 quarters · filed 2022-02-28 | $17.90M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $5.87M 10-Q · filed 2021-05-06 | $9.87M derived: sum of 2 quarters · filed 2022-02-28 | $12.26M derived: sum of 3 quarters · filed 2022-02-28 | $14.67M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $6.39M derived: sum of 2 quarters · filed 2022-02-28 | $8.80M derived: sum of 3 quarters · filed 2022-02-28 | $11.20M 10-K · filed 2022-02-28 |
| 2019-09-30 | $2.39M 10-Q · filed 2020-11-09 | $4.80M derived: sum of 2 quarters · filed 2020-11-09 | $7.20M 10-Q · filed 2020-11-09 | $9.60M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $2.41M 10-Q · filed 2020-08-10 | $4.81M 10-Q · filed 2020-08-10 | $7.21M derived: sum of 3 quarters · filed 2021-03-01 | $9.57M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $2.40M 10-Q · filed 2020-05-11 | $4.80M derived: sum of 2 quarters · filed 2021-03-01 | $7.16M derived: sum of 3 quarters · filed 2021-03-01 | $8.06M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $4.76M derived: sum of 2 quarters · filed 2021-03-01 | $5.67M derived: sum of 3 quarters · filed 2021-03-01 | $6.18M 10-K · filed 2021-03-01 |
| 2018-09-30 | $2.36M 10-Q · filed 2019-11-12 | $3.26M derived: sum of 2 quarters · filed 2019-11-12 | $3.77M 10-Q · filed 2019-11-12 | $4.27M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $903.00K 10-Q · filed 2019-08-08 | $1.41M 10-Q · filed 2019-08-08 | $1.91M derived: sum of 3 quarters · filed 2020-02-19 | $2.39M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $509.00K 10-Q · filed 2019-05-09 | $1.01M derived: sum of 2 quarters · filed 2020-02-19 | $1.49M derived: sum of 3 quarters · filed 2020-02-19 | $1.96M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $982.00K derived: sum of 2 quarters · filed 2020-02-19 | $1.45M derived: sum of 3 quarters · filed 2020-02-19 | $1.45M 10-K · filed 2020-02-19 |
| 2017-09-30 | $484.00K 10-Q · filed 2018-11-07 | $952.00K derived: sum of 2 quarters · filed 2018-11-07 | $956.00K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $468.00K 10-Q · filed 2018-08-08 | $473.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $5.00K 10-Q · filed 2018-05-08 |